PETHEMA (Program for the Study and Treatment of Haematological Malignances)が後援する臨床試験
合計2件
-
Wyeth is now a wholly owned subsidiary of PfizerPETHEMA (Program for the Study and Treatment of Haematological Malignances)完了
-
PENTA FoundationKarolinska Institutet; Centre Hospitalier Universitaire Saint Pierre; Centro Hospitalar do Porto; MRC Clinical Trials Unit at UCL と他の協力者積極的、募集していないHIV感染症 | COVID19 | C型肝炎 | 結核感染症